Avanos Medical, Inc. (AVNS) Tops Q4 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2021 Results
February 23, 2022 7:00 AM ESTALPHARETTA, Ga., Feb. 23, 2022 /PRNewswire/ --Â Avanos Medical, Inc. (NYSE: AVNS) today reported fourth quarter and full-year 2021 results.
"We are happy with our top line performance despite the extended duration of the COVID-19 pandemic and related supply chain headwinds," stated Joe Woody, Avanos' chief... More
